Skip to main content
. 2017 Apr 27;12(4):e0176231. doi: 10.1371/journal.pone.0176231

Table 2. Optimal cutoff point: Total number of lymph node metastasis vs. survival.

Training (n = 497) Testing (n = 300)
Methods Cutoff point Recurrence Death
Recurrence Death NMLN* Stage Histology NMLN*
Log-rank test 5 5 HR* 6.653 163.2 1 0.117 5.781
2 0.283
Likelihood ratio test 5 5 p 0.007 0.0004 1 0.004 0.035
2 0.281

* NMLN: number of metastatic lymph nodes, HR: hazard ratio. HR1 for histology was the hazard ratio of squamous cell carcinoma vs. other types, and HR2, adenocarcinoma vs. other types.